Jennifer O’nEill

Jennifer O’nEill

Auto-generated profile, based on publicly available information

Jennifer O’nEill

Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Aging
Verified
Journal Article
Open access
PDF file
MSMikki Schantell
Mikki Schantell
BTBrittany K. Taylor
Brittany K. Taylor
RSRachel K. Spooner
Rachel K. Spooner
PMPamela E. May
Pamela E. May
JOJennifer O’nEill
Jennifer O’nEill
TWTony W. Wilson
Tony W. Wilson
Background: Despite effective antiretroviral therapy, cognitive impairment and other aging-related comorbidities are more prevalent in people with HIV (PWH) than in the general population. Previous research examining DNA methylation has shown PWH exhibit accelerated biological aging. However, it is unclear how accelerated biological aging may affect neural oscillatory activity in virally suppressed PWH, and more broadly how such aberrant neural activity may impact neuropsychological performance. Methods: In the present study, participants (n = 134) between the ages of 23 – 72 years underwent a neuropsychological assessment, a blood draw to determine biological age via DNA methylation, and a visuospatial processing task during magnetoencephalography (MEG). Our analyses focused on the relationship between biological age and oscillatory theta (4-8 Hz) and alpha (10 - 16 Hz) activity among PWH (n=65) and seronegative controls (n = 69). Results: PWH had significantly elevated biological age when controlling for chronological age relative to controls. Biological age was differentially associated with theta oscillations in the left posterior cingulate cortex (PCC) and with alpha oscillations in the right medial prefrontal cortex (mPFC) among PWH and seronegative controls. Stronger alpha oscillations in the mPFC were associated with lower CD4 nadir and lower current CD4 counts, suggesting such responses were compensatory. Participants who were on combination antiretroviral therapy for longer had weaker theta oscillations in the PCC. Conclusions: These findings support the concept of interactions between biological aging and HIV status on the neural oscillatory dynamics serving visuospatial processing. Future work should elucidate the long-term trajectory and impact of accelerated aging on neural oscillatory dynamics in PWH.

19 July 2022 in Cerebral Cortex
Verified
Journal Article
Closed access
PDF file
CMChloe E Meehan
Chloe E Meehan
CEChristine M Embury
Christine M Embury
AWAlex I Wiesman
Alex I Wiesman
MSMikki Schantell
Mikki Schantell
SWSara L Wolfson
Sara L Wolfson
TWTony W Wilson
Tony W Wilson
Adults with HIV frequently develop a form of mild cognitive impairment known as HIV-associated neurocognitive disorder (HAND), but presumably cognitive decline in older persons with HIV could also be attributable to Alzheimer’s disease (AD). However, distinguishing these two conditions in individual patients is exceedingly difficult, as the distinct neural and neuropsychological features are poorly understood and most studies to date have only investigated HAND or AD spectrum (ADS) disorders in isolation. The current study examined the neural dynamics underlying visuospatial processing using magnetoencephalography (MEG) in 31 biomarker-confirmed patients on the ADS, 26 older participants who met criteria for HAND, and 31 older cognitively normal controls. MEG data were examined in the time–frequency domain, and a data-driven approach was utilized to identify the neural dynamics underlying visuospatial processing. Both clinical groups (ADS/HAND) were significantly less accurate than controls on the task and exhibited stronger prefrontal theta oscillations compared to controls. Regarding disease-specific alterations, those with HAND exhibited stronger alpha oscillations than those on the ADS in frontoparietal and temporal cortices. These results indicate both common and unique neurophysiological alterations among those with ADS disorders and HAND in regions serving visuospatial processing and suggest the underlying neuropathological features are at least partially distinct.

30 June 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
SSShawnalyn W Sunagawa
Shawnalyn W Sunagawa
SBSara Bares
Sara Bares
KSKimberly K Scarsi
Kimberly K Scarsi
APAnthony Podany
Anthony Podany
TMTimothy Mykris
Timothy Mykris
JHJoshua P Havens
Joshua P Havens
Long-acting cabotegravir/rilpivirine offers a low incidence of virologic failure. However, drug resistance can develop after discontinuation without an effective replacement regimen due to its long pharmacokinetic tail. We present a case of sustained virologic suppression 18 months after discontinuation of long-acting cabotegravir/rilpivirine despite inadequate adherence to oral antiretroviral therapy.

30 March 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JDJennifer M Davis
Jennifer M Davis
JOJennifer O’NEill
Jennifer O’NEill
ELElizabeth Lyden
Elizabeth Lyden
SBSara Bares
Sara Bares
Long-acting injectable cabotegravir plus rilpivirine offers an alternative to daily oral antiretroviral therapy, but insurance-related barriers can disrupt implementation. We examined the frequency and impact of insurance changes in a United States cohort and found that nearly half of patients experienced insurance changes, which could lead to delayed injections.

3 March 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JHJoshua P Havens
Joshua P Havens
JOJennifer O’NEill
Jennifer O’NEill
MKMaureen Kubat
Maureen Kubat
SSShawnalyn W Sunagawa
Shawnalyn W Sunagawa
JDJennifer M Davis
Jennifer M Davis
SBSara Bares
Sara Bares
Implementation of a long-acting injectable antiretroviral treatment program requires substantial multidisciplinary effort, particularly for program coordination, coverage/billing, and patient support/retention. As our program scaled to 113 patients over 2.5 years, a total of 2.25 full-time equivalents were required. Despite operational demands, clinical outcomes were favorable, supporting real-world feasibility and scalability.